UnitedHealth Group Incorporated $UNH Stake Trimmed by Smith Chas P & Associates PA Cpas

Smith Chas P & Associates PA Cpas trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 27.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 82,889 shares of the healthcare conglomerate’s stock after selling 31,192 shares during the quarter. UnitedHealth Group makes up approximately 2.5% of Smith Chas P & Associates PA Cpas’ portfolio, making the stock its 13th largest position. Smith Chas P & Associates PA Cpas’ holdings in UnitedHealth Group were worth $28,622,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Insigneo Advisory Services LLC grew its position in UnitedHealth Group by 8.2% during the 3rd quarter. Insigneo Advisory Services LLC now owns 8,697 shares of the healthcare conglomerate’s stock worth $3,003,000 after purchasing an additional 660 shares in the last quarter. Tillman Hartley LLC boosted its position in shares of UnitedHealth Group by 3.8% in the third quarter. Tillman Hartley LLC now owns 1,105 shares of the healthcare conglomerate’s stock worth $382,000 after buying an additional 40 shares during the period. Mcdonald Partners LLC raised its position in UnitedHealth Group by 3.1% during the third quarter. Mcdonald Partners LLC now owns 3,813 shares of the healthcare conglomerate’s stock valued at $1,317,000 after buying an additional 115 shares during the period. Griffith & Werner Inc. acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $3,039,000. Finally, Claro Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.6% in the 3rd quarter. Claro Advisors LLC now owns 6,375 shares of the healthcare conglomerate’s stock valued at $2,201,000 after purchasing an additional 39 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Weiss Ratings lowered shares of UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday. Royal Bank Of Canada cut their price objective on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. KeyCorp restated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. UBS Group reduced their price target on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Finally, Mizuho dropped their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating on the stock in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Trading Down 2.0%

Shares of NYSE:UNH opened at $288.93 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The company has a market cap of $261.72 billion, a P/E ratio of 21.91, a P/E/G ratio of 1.36 and a beta of 0.41. The stock’s 50-day moving average is $310.65 and its 200-day moving average is $326.33.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same quarter in the prior year, the company earned $6.81 EPS. The firm’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Investors of record on Monday, March 9th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.1%. The ex-dividend date is Monday, March 9th. UnitedHealth Group’s dividend payout ratio is presently 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.